Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced the appointment of Stephen Berenson to its Board of Directors. Mr. Berenson is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes Management Comments

Seres Therapeutics (MCRB) Tops Q2 EPS by 24c, Revenues BeatAugust 6, 2019 8:00 AM Seres Therapeutics Appoints Stephen Berenson to its Board of DirectorsAugust 6, 2019 7:00 AM